Results 211 to 220 of about 1,568,688 (370)

Development of a Disease Model for Predicting Postoperative Delirium Using Combined Blood Biomarkers

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Postoperative delirium, a common neurocognitive complication after surgery and anesthesia, requires early detection for potential intervention. Herein, we constructed a multidimensional postoperative delirium risk‐prediction model incorporating multiple demographic parameters and blood biomarkers to enhance prediction accuracy ...
Hengjun Wan, Huaju Tian, Cheng Wu, Yue Zhao, Daiying Zhang, Yujie Zheng, Yuan Li, Xiaoxia Duan   +7 more
wiley   +1 more source

Endovascular treatment for cerebral venous thrombosis: a multicenter study in China. [PDF]

Mil Med Res
Bian HT, Wang X, Liu GY, Zhou C, Meng R, Liu L, Duan JG, Yan F, Li CH, Li M, Hui W, Zhang XX, Zhao D, Li YP, Fang Q, Kang DZ, Zeng HL, Liang ZJ, Shi ZH, Yue W, Sun QJ, Chen GS, Song JL, Yan ZR, Ji QH, Wang KJ, Tong LS, Hu X, Cao WF, Yan W, Gao RJ, Li Q, Wang JY, Liu Y, Wang BJ, Wang XH, Yao ST, Lang Y, Li HP, Anderson CS, Ji XM, RETAIN-CH Investigators and Coordinators.   +41 more
europepmc   +1 more source

A NEUROLOGIC EVALUATION OF THE CUTANEOUS HISTAMINE REACTION 1 [PDF]

, 1950
Irving S. Cooper
openalex   +1 more source

Clinical Phenotyping of Long COVID Patients Evaluated in a Specialized Neuro‐COVID Clinic

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To report Long COVID characteristics and longitudinal courses of patients evaluated between 4/14/21–4/14/22 at the University of Pennsylvania Neurological COVID Clinic (PNCC), including clinical symptoms, neurological examination findings, and neurocognitive screening tests from a standardized PNCC neurological evaluation approach ...
Luana D. Yamashita, Neel Desai, Abigail R. Manning, Caitlin Pileggi, Sara Manning Peskin, Danielle K. Sandsmark, Dennis L. Kolson, Matthew K. Schindler   +7 more
wiley   +1 more source

Economic burden of secondary progressive multiple sclerosis: DISCOVER study. [PDF]

BMC Health Serv Res
Oreja-Guevara C, Meca-Lallana JE, Gómez-Estévez I, Ara JR, Pérez MÁH, Gil JG, Torres AMA, de la Fuente BP, Ramió-Torrentà L, Madueño SE, Gascón-Giménez F, Casanova B, Martínez-Yélamos S, Valcárcel MA, Ginés MLM, Montero YEB, Real AML, González-Quintanilla V, de Silanes CL, Martínez-Rodríguez JE, Costa-Frossard L, Redondo MG, Fontcuberta AL, Castellanos-Pinedo F, Merino JAG, Fernández CM, Castillo-Triviño T, Meca-Lallana V, Martínez JP, Rodríguez-Antigüedad A, González JMP, Morales EA, Molina IP, Sánchez DMS, Varo NH, Vázquez MA, Barrios JMR, Río J.   +37 more
europepmc   +1 more source

MODERN PROBLEMS IN NEUROLOGY. [PDF]

, 1928
David Slight
openalex   +1 more source

Abnormal Synchronization Between Cortical Delta Power and Ripples in Hippocampal Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Discriminating between epileptogenic and physiological ripples in the hippocampus is important for identifying epileptogenic (EP) zones; however, distinguishing these ripples on the basis of their waveforms is difficult. We hypothesized that the nocturnal synchronization of hippocampal ripples and cortical delta power could be used ...
Takamitsu Iwata, Takufumi Yanagisawa, Ryohei Fukuma, Yuji Ikegaya, Satoru Oshino, Naoki Tani, Hui Ming Khoo, Hidenori Sugano, Yasushi Iimura, Hiroharu Suzuki, Haruhiko Kishima   +10 more
wiley   +1 more source

Editorial: Artificial intelligence and telemedicine: applications to vascular neurology, neuro-ophthalmology, neuro-otology, and epilepsy: advancing teleneurology with artificial intelligence and digital biomarkers. [PDF]

Front Neurol
Browne JD, Green KE.
europepmc   +1 more source

Neurological Emergencies [PDF]

Emergency Medicine International, 2012
Joseph R. Shiber, Chamisa Macindoe, Oliver Flower, William A. Knight IV, Julian Bösel   +4 more
openaire   +3 more sources

Phase 1, First‐In‐Human, Single‐/Multiple‐Ascending Dose Study of Iluzanebart in Healthy Volunteers

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of iluzanebart, a fully human monoclonal antibody TREM2 (triggering receptor expressed on myeloid cells 2) agonist, after single‐ (SAD) and multiple‐ascending‐dose (MAD) administration.
Andreas Meier, Spyros Papapetropoulos, Andrew Marsh, Kelly Neelon, David Stiles, Ryan O'Mara, Evan A. Thackaberry, Marco Colonna, Raj Rajagovindan   +8 more
wiley   +1 more source